South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Size and Share 2023 | Upcoming Trends, Development Status and in-Depth Analysis Research Report by 2028

The South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics market. This report explores all the key factors affecting the growth of the global South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics market, including demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Get PDF Sample Report Now! @ https://www.prudentmarkets.com/sample-request/141740/

Report Overview

The South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics market size stood at around USD 136 million in 2020 and is projected to reach xx million by 2028, exhibiting a CAGR of around xx% during the forecast period.

Lung cancer is divided into non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). NSCLC metastasizes to other organs slower in comparison to SCLC, and microscopically, SCLC is composed of much smaller cells. If untreated, SCLC can be fatal in a few weeks, in contrast to most cases of NSCLC. Approximately 85 % of lung cancer patients in South Korea are affected with non-small cell lung cancer (NSCLC), creating a plethora of opportunities for pharmaceutical companies to expand their portfolios of drugs for this disease.

In 2020, South Koreas NSCLC market experienced a 15% increase compared to the previous year, and the average annual growth rate for the past three years has been 18%.

Market Drivers

South Korea reported 28,651 new cases of Lung Cancer in 2020 and more than 80% of the reported cases were of NSCLC, increasing burden of the disease is a major factor driving the NSCLC market. South Korea's aging population presents drug manufacturers with a vast market, as patients are generally aged 65 or above at the time of diagnosis. In addition to this, the majority of patients are in stage III or IV at the time of diagnosis, where the primary treatment involves drugs. The US Food and Drug Administration (FDA) is implementing an accelerated approval system that shortens clinical trials for serious diseases, this will further propel the market growth.

Pharmaceutical companys R&D efforts will be boosted by South Korea's advanced medical and research infrastructure, combined with the growing biotechnology industry in the forecasted period. Low levels of early diagnosis, lack of a regular screening program are the factors that impede the growth of the market.

To Know More About COVID-19 Impact On South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market @ https://www.prudentmarkets.com/sample-request/141740/

Market Segmentation

By Therapy:

According to the type of therapy used in treating NSCLC, market is segmented into targeted therapy, immunotherapy, and chemotherapy.

By Drug Class:

According to the class of drugs market is segmented into angiogenesis inhibitors, kinase inhibitors, epidermal growth factor receptor blockers, microtubule stabilizers, PD-1/PD-L1 inhibitors, and folate antagonists. Angiogenesis inhibitors were the most in demand in the non-small cell lung cancer treatment market due to the high efficacy of the drug.

Top Players

Affluent players in the NSCLC domestic market are AstraZeneca Korea, Boehringer Ingelheim, Yuhan Corporation, Eli Lilly, Bristol Myers Squibb Company, Novartis, F. Hoffmann-La Roche, Janssen Pharmaceuticals, Ono Pharmaceuticals, Takeda Pharmaceuticals Korea, and others.

In January 2021, South Korea's health authorities granted marketing authorization to Yuhan Corp.'s Leclaza (lazertinib mesylate monohydrate) for the treatment of patients with non-small cell lung cancer (NSCLC).

Prudent Markets provides attractive discounts that fit your needs. Customization of the reports as per your requirement is also offered. Get in touch with our sales team, who will guarantee you a report that suits your needs.

Speak To Our Analyst For A Discussion On The Above Findings, And Ask For A Discount On The Report @ https://www.prudentmarkets.com/discount-request/141740/

The report covers the competitive analysis of the market. As the demand is driven by a buyer's paying capacity and the rate of item development, the report shows the important regions that will direct growth. This section exclusively shares insight into the budget reports of big-league members of the market helping key players and new entrants understand the potential of investments in the Global South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market. It can be better employed by both traditional and new players in the industry for complete know-how of the market.

Strategic Points Covered in Table of Content of Global South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market:

Chapter 1: Introduction, market driving force product Objective of Study and Research Scope the South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics market
Chapter 2: Exclusive Summary - the basic information of the South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market.
Chapter 3: Displaying the Market Dynamics- Drivers, Trends and Challenges & Opportunities of the South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics
Chapter 4: Presenting the South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market Factor Analysis, Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.
Chapter 5: Displaying the by Type, End User and Region/Country
Chapter 6: Evaluating the leading manufacturers of the South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics market which consists of its Competitive Landscape, Peer Group Analysis, BCG Matrix & Company Profile
Chapter 7: To evaluate the market by segments, by countries and by Manufacturers/Company with revenue share and sales by key countries in these various regions
Chapter 8 & 9: Displaying the Appendix, Methodology and Data Source

Any Questions? Feel Free To Enquire Here. We Will put you on the Right Path @ https://www.prudentmarkets.com/enquiry-request/141740/

Free Customization on the basis of client requirements on Immediate purchase:
1- Free country-level breakdown of any 5 countries of your interest.
2- Competitive breakdown of segment revenue by market players.

Customization of the Report:
This report can be customized to meet the client's requirements. Please connect with our sales team (sales@prudentmarkets.com), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +91 83560 50278 || USA/Canada(Toll Free): 1800-601-6071 to share your research requirements.

Get ready to Recognize the pros and cons of the regulatory framework, local reforms, and its effect on the Industry. Understand how the Leaders in Intelligent Network are keeping themselves one stage forward with our most up-to-date survey analysis.

In conclusion, the South Korea Non-Small Cell Lung Cancer (NSCLC) Therapeutics Market report is a genuine source for accessing the research data which is projected to exponentially grow your business. The report provides information such as economic scenarios, benefits, limits, trends, market growth rates, and figures. SWOT analysis and PESTLE analysis is also incorporated in the report.

Contact Us:
Allan Carter
Andheri, Maharashtra, 400102
USA/Canada(Toll Free): 1800-601-6071
Direct Line: +91 83560 50278
Mail: sales@prudentmarkets.com
Web: www.prudentmarkets.com

About Us:
We are leaders in market analytics, business research, and consulting services for Fortune 500 companies, start-ups, financial & government institutions. Since we understand the criticality of data and insights, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. To be at our client's disposal whenever they need help on market research and consulting services. We also aim to be their business partners when it comes to making critical business decisions around new market entry, M&A, competitive Intelligence and strategy.

This release was published on openPR.